BloombergSen Inc. cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 7.2% during the fourth quarter, HoldingsChannel reports. The firm owned 255,918 shares of the company’s stock after selling 19,807 shares during the quarter. HCA Healthcare comprises 8.7% of BloombergSen Inc.’s holdings, making the stock its 4th largest position. BloombergSen Inc.’s holdings in HCA Healthcare were worth $119,478,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC lifted its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the last quarter. Jump Financial LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $2,073,000. Finally, Sei Investments Co. lifted its stake in shares of HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after acquiring an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research analysts have commented on the company. Leerink Partners reduced their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. UBS Group raised their price objective on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. Sanford C. Bernstein reduced their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a report on Tuesday, April 28th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a report on Tuesday, April 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $515.77.
HCA Healthcare Trading Up 0.5%
Shares of NYSE:HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The business’s fifty day simple moving average is $465.16 and its 200-day simple moving average is $483.61. The company has a market capitalization of $87.49 billion, a PE ratio of 13.56, a P/E/G ratio of 1.24 and a beta of 1.18.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Research analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is currently 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
